SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-17-061560
Filing Date
2017-10-10
Accepted
2017-10-10 16:05:26
Documents
1
Group Members
KOH, BONGSHAH, NIMISHVHCP CO-INVESTMENT HOLDINGS II, LLCVHCP MANAGEMENT II, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G a17-23059_1sc13g.htm SC 13G 227407
  Complete submission text file 0001104659-17-061560.txt   229176
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filed by) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 530 FIFTH AVENUE 22ND FLOOR NEW YORK NY 10036
Business Address 530 FIFTH AVENUE 22ND FLOOR NEW YORK NY 10036 650 475 3734
Venrock Healthcare Capital Partners II, L.P. (Subject) CIK: 0001602264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90137 | Film No.: 171130524